Impact of histological response after neoadjuvant chemoradiotherapy on recurrence-free survival in UICC-T3 pancreatic adenocarcinoma but not in UICC-T4

Pancreas

Volumn 41, Issue 1, 2012, Pages 130-136

  Murata, Yasuhiro ^a   Mizuno, Shugo ^a   Kishiwada, Masashi ^a   Hamada, Takashi ^a   Usui, Masanobu ^a   Sakurai, Hiroyuki ^a   Tabata, Masami ^a   Inoue, Hiroyuki ^a   Shiraishi, Taizo ^a   Isaji, Shuji ^a  

^a MIE UNIVERSITY   (Japan)

Author keywords

Evans s histopathological criteria; gemcitabine; histological response; locally advanced pancreatic cancer; neoadjuvant chemoradiotherapy; survival analysis

Indexed keywords

GEMCITABINE;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CHEMORADIOTHERAPY; DISEASE FREE SURVIVAL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PANCREAS ADENOCARCINOMA; PANCREAS RESECTION; PANCREATICODUODENECTOMY; PRIORITY JOURNAL; PROGNOSIS; TREATMENT RESPONSE;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; CHEMORADIOTHERAPY; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PANCREAS; PANCREATECTOMY; PANCREATIC NEOPLASMS; PROGNOSIS; TREATMENT OUTCOME;

EID: 84655161429     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0b013e3182236442     Document Type: Article

References (31)

1. Conlon KC, Klimstra DS, Brennan MF. Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors. Ann Surg. 1996;223(3):273-279. (Pubitemid 26086718)
2. Richter A, Niedergethmann M, Sturm JW, et al. Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience. World J. Surg. 2003;27(3): 324-329. (Pubitemid 36920145)
3. Willett CG, Lewandrowski K, Warshaw AL, et al. Resection margins in carcinoma of the head of pancreas. Implications for radiation therapy. Ann Surg. 1993;217(2):144-148. (Pubitemid 23059285)
4. Spitz F, Abruzzese J, Lee J, et al. Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas. J. Clin Oncol. 1997;15(3): 928-937. (Pubitemid 27106274)
5. White RR, Hurwitz HI, Morse MA, et al. NeoadjuVant chemoradiation for localized adenocarcinoma of the pancreas. Ann Surg Oncol. 2001;8(10):758-765. (Pubitemid 34003323)
6. EVans DB, Varadhachary GR, Crane CH, et al. Preoperative gemcitabine-based chemoradiation for patients with respectable adenocarcinoma of the pancreatic head. J. Clin Oncol. 2008;26(21):3496-3502.
7. Ohigashi H, Ishikawa O, Eguchi H, et al. Feasibility and efficacy of combination therapy with preoperative full-dose gemcitabine, concurrent three-dimensional conformal radiation, surgery, and postoperative liver perfusion chemotherapy for T3-pancreatic cancer. Ann Surg. 2009;250(1):88-95.
8. Talamonti MS, Small W Jr, Mulcahy MF, et al. A multi-institutional phase II trial of preoperative full-dose gemcitabine and concurrent radiation for patients with potentially resectable pancreatic carcinoma. Ann Surg Oncol. 2006;13(2):150-158. (Pubitemid 43157408)
9. Varadhachary GR, Wolff RA, Crane CH, et al. Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head. J. Clin Oncol. 2008;26(21):3487-3495.
10. Le Scodan R, Mornex F, Girard N, et al. Preoperative chemoradiation in potentially resectable pancreatic adenocarcinoma: feasibility, treatment effect evaluation and prognostic factors, analysis of the SFRO-FFCD 9704 trial and literature review. Ann Oncol. 2009;20(8):1387-1396.
11. Ishikawa O, Ohigashi H, Imaoka S, et al. Is the long-term survival rate improved by preoperative irradiation prior to Whippleïs procedure for adenocarcinoma of the pancreatic head? Arch Surg. 1994;129(10): 1075-1080. (Pubitemid 24320802)
12. Ohigashi H, Ishikawa O, Eguchi H, et al. Feasibility and efficacy of combination therapy with preoperative and postoperative chemoradiation, extended pancreatectomy, and postoperative liver perfusion chemotherapy for locally adVanced cancers of the pancreatic head. Ann Surg Oncol. 2005;12(8):629-636. (Pubitemid 41126092)
13. Kim HJ, Czischke K, Brennan MF, et al. Does neoadjuVant chemoradiation downstage locally adVanced pancreatic cancer? J. Gastrointest Surg. 2002;6(5):763-769. (Pubitemid 40433496)
14. Massucco P, Capussotti L, Magnino A, et al. Pancreatic resections after chemoradiotherapy for locally adVanced ductal adenocarcinoma: Analysis of perioperative outcome and survival. Ann Surg Oncol. 2006;13(9):1201-1208. (Pubitemid 44440421)
15. Aristu J, Cañón R, Pardo F, et al. Surgical resection after preoperative chemoradiotherapy benefits selected patients with unresectable pancreatic cancer. Am J. Clin Oncol. 2003;26(1):30-36. (Pubitemid 36205894)
16. Sa Cunha A, Rault A, Laurent C, et al. Surgical resection after radiochemotherapy in patients with unresectable adenocarcinoma of the pancreas. J. Am Coll Surg. 2005;201(3):359-365. (Pubitemid 41206773)
17. EVans DB, Rich TA, Byrd DR, et al. Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas. Arch Surg. 1992;127(11):1335-1339.
18. Breslin TM, Hess KR, Harbison DB, et al. NeoadjuVant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration. Ann Surg Oncol. 2001;8(2):123-132. (Pubitemid 32199408)
19. White RR, Xie HB, Gottfried MR, et al. Significance of histological response to preoperative chemoradiotherapy for pancreatic cancer. Ann Surg Oncol. 2005;12(3):214-221. (Pubitemid 40568908)
20. Sobin L, Wittekind C, eds. TNM Classification of Malignant Tumors. 6th ed. New York, NY: Wiley-Liss; 2002.
21. Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J. Natl Cancer Inst. 2000;92(3):205-216. (Pubitemid 30099779)
22. Burris HA 3rd, Moore MJ, Andersen J, et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with adVanced pancreas cancer: A randomized trial. J. Clin Oncol. 1997;15(6):2403-2413. (Pubitemid 27251144)
23. Lawrence TS, Chang EY, Hahn TM, et al. Radiosensitization of pancreatic cancer cells by 2ï,2ï-difluoro-2ï-deoxycytidine. Int J. Radiat Oncol Biol Phys. 1996;34(4):867-872.
24. Small W Jr, Berlin J, Freedman GM, et al. Full-dose gemcitabine with concurrent radiation therapy in patients with nonmetastatic pancreatic cancer: A multicenter phase II trial. J. Clin Oncol. 2008;26(6):942-947. (Pubitemid 351398088)
25. Joensuu TK, Kiviluoto T, Kärkkäinen P, et al. Phase IYII trial of twice-weekly gemcitabine and concomitant irradiation in patients undergoing pancreaticoduodenectomy with extended lymphadenectomy for locally adVanced pancreatic cancer. Int J. Radiat Oncol Biol Phys. 2004;60(2):444-452. (Pubitemid 39233463)
26. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Pancreatic Adenocarcinoma. V2. 2010. Available at: http://www.nccn.org/professionals/physician-gls/pdf/ pancreatic.pdf. Accessed February 6, 2011.
27. Satoi S, Yanagimoto H, Toyokawa H, et al. Surgical results after preoperative chemoradiation therapy for patients with pancreatic cancer. Pancreas. 2009;38(3):282-288.
28. Bassi C, Salvia R, Butturini G, et al. Value of regional lymphadenectomy in pancreatic cancer. HPB (Oxford). 2005;7(2): 87-92. (Pubitemid 40767042)
29. Hoffman JP, Lipsitz S, Pisansky T, et al. Phase II trial of preoperative radiation therapy and chemotherapy for patients with localized, respectable adenocarcinoma of pancreas: An Eastern Cooperative Oncology Group study. J. Clin Oncol. 1998;16(1):317-323. (Pubitemid 28041615)
30. Staley CA, Lee JE, Cleary KR, et al. Preoperative chemoradiation, pancreticoduodenectomy, and intraoperative radiation therapy for adenocarcinoma of the pancreatic head. Am J. Surg. 1996;171(1):118-125. (Pubitemid 26028205)
31. Gregoire V, Hittelman WN, Rosier JF, et al. Chemo-radiotherapy: Radiosensitizing nucleoside analogues [review]. Oncol Rep. 1999;6(5):949-957.